NEXT
Sign in to follow
Search Results

0 results for ''Motley Rice''

You can use to get even better search results
City of Providence, Rhode Island v. Abbvie Inc.
Publication Date: 2020-10-21
Practice Area: Antitrust | Class Actions | Patent Litigation
Industry: Pharmaceuticals
Court: U.S. District Court for the Southern District of New York, U.S. - SDNY
Judge: District Judge Lewis Liman
Attorneys:
For plaintiff:
For defendant:
Case number: 20-CV-5538

Appointment of Co-Lead Class Counsel for End-Payor Class in Drug Action Explained

October 09, 2020 | Law.com

Opioid Trials in W.Va., Ohio Placed on Hold Due to COVID-19 Pandemic

This week, federal judges postponed high-profile trials over the opioid crisis due to the COVID-19 pandemic, further complicating efforts to resolve thousands of lawsuits brought by cities, counties and states.
5 minute read
September 24, 2020 | The Recorder

Appeals Court Reverses 'Negotiation Class' Created for Opioid Settlement

A team of lawyers challenging the "negotiation class" includes Sonya Winner, a San Francisco partner at Covington & Burling.
7 minute read
September 24, 2020 | Law.com

Appeals Court Reverses 'Negotiation Class' Created for Opioid Settlement

Thursday's decision is the latest by the U.S. Court of Appeals for the Sixth Circuit to reverse a ruling by U.S. District Judge Dan Polster, who oversees the opioid multidistrict litigation, and is a setback for those negotiating a global settlement.
7 minute read
In re: Plavix Mktg., Sales Practices, & Prod. Liab. Litig.
Publication Date: 2020-09-14
Practice Area: Health Care Law
Industry: Federal Government | Pharmaceuticals | State and Local Government
Court: U.S. Court of Appeals for the Third Circuit
Judge: Justice Bibas
Attorneys:
For plaintiff: William H. Narwold and Mathew P. Jasinski (Motley Rice); W. Scott Simmer (Baron & Budd)
For defendant: Anand Agneshwar (Arnold & Porter Kaye Scholer); Murad Hussain and Kirk Ogrosky (Arnold & Porter Kaye Scholer); Gavin J. Rooner (Lowenstein Sandler)
Case number: 18-2472

FCA First-to-File Rule Did Not Bar Successor LLP from Entering Existing Qui Tam Action

September 01, 2020 | New Jersey Law Journal

In Deepening Circuit Split, 3rd Circuit Revives Qui Tam Lawsuit Over Plavix

The panel found that a rule should be treated as nonjurisdictional unless Congress clearly states that it is jurisdictional. Sanofi and Bristol did not identify any language, nor did the panel see any, that plainly shows Congress imbued the first-to-file bar with jurisdictional consequences, the court said.
4 minute read
August 28, 2020 | Litigation Daily

Litigators of the Week: The Plaintiffs' Team Behind the $1.6B Essure Settlement

Three plaintiffs lawyers driving the deal—Fidelma Fitzpatrick of Motley Rice, Edward Wallace of Wexler Wallace, and Erin Copeland of Fibich, Leebron, Copeland & Briggs—say the judge overseeing the coordinated state court cases in California kept them moving forward even as pandemic closures pushed off scheduled trial dates this spring.
11 minute read
August 26, 2020 | Law.com

Bayer Reached $1.6 Billion Settlement Over Essure in Wake of Trial Delays Due to COVID-19. Plus: Flint Water Accord to Benefit Children

Deal over sterilization device took shape while parties were immersed in extended trial preparation, plaintiffs' counsel says
5 minute read
August 20, 2020 | The Recorder

Bayer Seeks to Resolve Essure Claims in $1.6B Proposed Settlement

Motley Rice's Fidelma Fitzpatrick, who is lead counsel of the plaintiffs' executive committee for the California Joint Council Coordinated Proceedings and helped to negotiate the deal, said the proposed settlement would provide expedited relief to thousands of women.
3 minute read
August 20, 2020 | Daily Business Review

Bayer Agrees to Pay $1.6 Billion to Resolve Essure Claims

Plaintiffs attorneys say the proposed settlement offers expedited relief to thousands of women who used the intrauterine device, which was taken off the market two years ago.
3 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources